Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Sees Significant Growth in Short Interest

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) saw a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 1,073,400 shares, an increase of 22.9% from the March 31st total of 873,500 shares. Currently, 0.5% of the company’s shares are sold short. Based on an average daily trading volume, of 300 shares, the short-interest ratio is currently 3,578.0 days.

Recordati Industria Chimica e Farmaceutica Price Performance

Recordati Industria Chimica e Farmaceutica stock opened at $56.04 on Monday. The stock’s 50 day moving average is $53.95 and its 200 day moving average is $53.79. Recordati Industria Chimica e Farmaceutica has a one year low of $49.00 and a one year high of $56.04. The firm has a market cap of $11.56 billion, a P/E ratio of 28.02 and a beta of 0.26.

Recordati Industria Chimica e Farmaceutica Company Profile

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.